PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-Apr-2021 IGEA to secure convertible bond commitment with Negma Group IGEA Pharma N.V.
15-Apr-2021 Nouscom Activates Commercial Product License for ProBioGen’s Proprietary Vaccine Production Cell Line AGE1.CR.pIX® B3C newswire
15-Apr-2021 NICE recommends ULTOMIRIS ® (ravulizumab) for patients with Paroxysmal Nocturnal H a emoglobinuria (PNH) Alexion Pharma UK
15-Apr-2021 Audited results for the year ended 31 December 2020 Destiny Pharma plc
15-Apr-2021 Switzerland: BioVersys Receives €20 Million in EU Financing to Support Development of New Antibiotics BioVersys
15-Apr-2021 HUMMINGBIRD BIOSCIENCE PRESENTS PRE-CLINICAL DATA ON ITS NEXT-GENERATION BCMA-TACI DUAL-SPECIFIC T CELL ENGAGER AT 2021 AACR ANNUAL MEETING Hummingbird Bioscience
15-Apr-2021 Intravacc announces positive preclinical data for its OMV- based Lyme vaccine Intravacc
15-Apr-2021 Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery to pioneer reactive fragment screening in drug discovery Francis Crick Institute and GSK
15-Apr-2021 Moderna Announces Clinical Progress from its Industry-Leading mRNA Vaccine Franchise and Continues Investments to Accelerate Pipeline Development Moderna
15-Apr-2021 STROKE REHABILITATION: TECHNOLOGICAL SUPPORT WITH ROBOTS AND FUNCTIONAL ELECTRICAL STIMULATION PUT TO TEST Austrian Institute for Health Technology Assessment (AIHTA)
15-Apr-2021 PTC Therapeutics Launches the PTC Pinpoint Direct™ Program for Patient-Initiated Genetic Testing PTC Therapeutics
15-Apr-2021 FORXIGA (DAPAGLIFLOZIN) ACCEPTED FOR USE WITHIN NHS SCOTLAND FOR THE TREATMENT OF SYMPTOMATIC CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN ADULTS[1] AstraZeneca
15-Apr-2021 4D pharma to Participate in Jefferies Microbiome-Based Therapeutics Summit 4D Pharma
15-Apr-2021 Veramed achieves ‘World Class’ 3 star Best Companies accreditation Veramed
15-Apr-2021 Relief Reports 2020 Financial Results and Provides Business Update RELIEF THERAPEUTICS Holdings AG
14-Apr-2021 IGEA and its CFO end collaboration IGEA Pharma N.V.
14-Apr-2021 Drägerwerk AG & Co. KGaA: preliminary result for the first quarter 2021. Net sales and earnings considerably above prior year. Drägerwerk AG & Co. KGaA
14-Apr-2021 Abivax completes induction treatment of last patient in ABX464 phase 2b clinical study in ulcerative colitis ABIVAX
14-Apr-2021 ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers ATMPS Ltd
14-Apr-2021 ​​​​​​​Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin Eckert & Ziegler Strahlen- und Medizintechnik AG